CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ibarra-lecue

OPENALEX: A5029724484↗ORCID: 0000-0001-8819-4644↗

Affiliations

Organizations

Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ES Columbia Universityauthorship · US New York Psychoanalytic Society and Instituteauthorship · US New York State Psychiatric Instituteauthorship University of the Basque Countryauthorship · ES

Public evidence

3 connected articles

Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients.2022 · Europe PMC Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway.2018 · PubMed Central Open Access Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex.2016 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Ibarra-lecue - Medical Cannabis Research Engine